Literature DB >> 20528008

Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.

Iftekhar Mahmood1.   

Abstract

BACKGROUND AND
OBJECTIVE: Interspecies pharmacokinetic scaling is widely used to predict pharmacokinetic parameters in adult humans but has not been used for the prediction of pharmacokinetic parameters in children. The current study was undertaken to evaluate whether or not drug clearance in children from adult rat, dog and human clearance values could be predicted allometrically.
METHODS: Four methods (simple allometry, maximum lifespan potential [MLP], MLP with an empirical correction factor and a fixed exponent of 0.75 in association with adult data) were used for the prediction of drug clearance in children. The first three methods included adult animal (rat and dog) data and human data, whereas the fixed exponent of 0.75 included only adult human data.
RESULTS: The results of this study indicated that simple allometry would systematically overpredict drug clearance in children, whereas application of MLP would underpredict drug clearance in children. Therefore, an empirical correction factor was introduced into MLP, which substantially improved the prediction of drug clearance in children. Prediction based on a fixed exponent of 0.75 and adult human clearance was highly erratic and inferior to the prediction of drug clearance in children from MLP or MLP with an empirical correction factor.
CONCLUSIONS: Overall, the results of the study indicated that interspecies scaling using adult rat, dog and human clearance values could be useful to predict drug clearance in children in different age groups.

Entities:  

Mesh:

Year:  2010        PMID: 20528008     DOI: 10.2165/11531830-000000000-00000

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  98 in total

1.  Disposition of irbesartan, an angiotensin II AT1-receptor antagonist, in mice, rats, rabbits, and macaques.

Authors:  H Davi; C Tronquet; G Miscoria; L Perrier; P DuPont; J Caix; J Simiand; Y Berger
Journal:  Drug Metab Dispos       Date:  2000-01       Impact factor: 3.922

2.  Maturation and growth of renal function: dosing renally cleared drugs in children.

Authors:  W L Hayton
Journal:  AAPS PharmSci       Date:  2000

3.  Pharmacokinetics of propofol in young children after a single dose.

Authors:  C Saint-Maurice; I D Cockshott; E J Douglas; M O Richard; J L Harmey
Journal:  Br J Anaesth       Date:  1989-12       Impact factor: 9.166

4.  Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearance.

Authors:  Iftekhar Mahmood; Martin David Green; J Edward Fisher
Journal:  J Clin Pharmacol       Date:  2003-07       Impact factor: 3.126

Review 5.  Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants.

Authors:  Gary Ginsberg; Dale Hattis; Babasaheb Sonawane
Journal:  Toxicol Appl Pharmacol       Date:  2004-07-15       Impact factor: 4.219

6.  Pharmacokinetic, biliary excretion, and metabolic studies of 14C-furosemide in the rat.

Authors:  J Prandota; A W Pruitt
Journal:  Xenobiotica       Date:  1991-06       Impact factor: 1.908

7.  Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia.

Authors:  M G Donelli; M Zucchetti; A Robatto; V Perlangeli; M D'Incalci; G Masera; M R Rossi
Journal:  Med Pediatr Oncol       Date:  1995-03

8.  Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog.

Authors:  M Michiels; J Monbaliu; R Hendriks; R Geerts; R Woestenborghs; J Heykants
Journal:  Arzneimittelforschung       Date:  1987-10

9.  Pharmacokinetics of fentanyl in neonates.

Authors:  D E Koehntop; J H Rodman; D M Brundage; M G Hegland; J J Buckley
Journal:  Anesth Analg       Date:  1986-03       Impact factor: 5.108

Review 10.  Linezolid pharmacokinetics in pediatric patients: an overview.

Authors:  Gail L Jungbluth; Ian R Welshman; Nancy K Hopkins
Journal:  Pediatr Infect Dis J       Date:  2003-09       Impact factor: 2.129

View more
  5 in total

1.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

Review 2.  Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings.

Authors:  Iftekhar Mahmood
Journal:  Clin Pharmacokinet       Date:  2014-04       Impact factor: 6.447

3.  Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.

Authors:  Iftekhar Mahmood; Anna Cheng; Edward Brauer; Rita Humeniuk
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

4.  First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole.

Authors:  Wei Zhao; Chantal Le Guellec; Daniel K Benjamin; William W Hope; Thomas Bourgeois; Kevin M Watt; Johannes N van den Anker; Boris Matrot; Harri Saxen; Kalle Hoppu; Paolo Manzoni; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

Review 5.  Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development.

Authors:  Kefei Wang; Kun Jiang; Xiaoyi Wei; Yulan Li; Tiejie Wang; Yang Song
Journal:  AAPS PharmSciTech       Date:  2021-07-26       Impact factor: 3.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.